Challenges in the Treatment of Chronic Wounds

被引:1532
作者
Frykberg, Robert G. [1 ]
Banks, Jaminelli [1 ]
机构
[1] Phoenix VA Hlth Care Syst, Phoenix, AZ 85012 USA
关键词
DIABETIC FOOT ULCERS; MESENCHYMAL STEM-CELLS; HYPERBARIC-OXYGEN THERAPY; EPIDERMAL-GROWTH-FACTOR; VACUUM-ASSISTED CLOSURE; AMNIOTIC MEMBRANE ALLOGRAFTS; RANDOMIZED CONTROLLED-TRIAL; VENOUS LEG ULCERS; CONVENTIONAL COMPRESSION DRESSINGS; EVIDENCE-BASED MANAGEMENT;
D O I
10.1089/wound.2015.0635
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Significance: Chronic wounds include, but are not limited, to diabetic foot ulcers, venous leg ulcers, and pressure ulcers. They are a challenge to wound care professionals and consume a great deal of healthcare resources around the globe. This review discusses the pathophysiology of complex chronic wounds and the means and modalities currently available to achieve healing in such patients. Recent Advances: Although often difficult to treat, an understanding of the underlying pathophysiology and specific attention toward managing these perturbations can often lead to successful healing. Critical Issues: Overcoming the factors that contribute to delayed healing are key components of a comprehensive approach to wound care and present the primary challenges to the treatment of chronic wounds. When wounds fail to achieve sufficient healing after 4 weeks of standard care, reassessment of underlying pathology and consideration of the need for advanced therapeutic agents should be undertaken. However, selection of an appropriate therapy is often not evidence based. Future Directions: Basic tenets of care need to be routinely followed, and a systematic evaluation of patients and their wounds will also facilitate appropriate care. Underlying pathologies, which result in the failure of these wounds to heal, differ among various types of chronic wounds. A better understanding of the differences between various types of chronic wounds at the molecular and cellular levels should improve our treatment approaches, leading to better healing rates, and facilitate the development of new more effective therapies. More evidence for the efficacy of current and future advanced wound therapies is required for their appropriate use.
引用
收藏
页码:560 / 582
页数:23
相关论文
共 301 条
  • [1] Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration
    Abbott, CA
    Vileikyte, L
    Williamson, S
    Carrington, AL
    Boulton, AJM
    [J]. DIABETES CARE, 1998, 21 (07) : 1071 - 1075
  • [2] The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial
    Abidia, A
    Laden, G
    Kuhan, G
    Johnson, BF
    Wilkinson, AR
    Renwick, PM
    Masson, EA
    McCollum, PT
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2003, 25 (06) : 513 - 518
  • [3] American Diabetes Association, 1999, Diabetes Care, V22, P1354
  • [4] Amini S, 2013, WOUNDS, V25, P193
  • [5] Andros G, 2006, OSTOMY WOUND MANAG, P1
  • [6] Angirasa AK, 2006, OSTOMY WOUND MANAG, V52, P60
  • [7] [Anonymous], 2014, Prevention and treatment of pressure ulcers: Quick reference guide
  • [8] [Anonymous], ANN PLAST SURG
  • [9] Practical guidelines on the management and prevention of the diabetic foot - Based upon the International Consensus on the Diabetic Foot (2007) prepared by the International Working Group on the Diabetic Foot
    Apelqvist, J.
    Bakker, K.
    van Houtum, W. H.
    Schaper, N. C.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2008, 24 : S181 - S187
  • [10] Vacuum-assisted closure: A new method for wound control and treatment: Clinical experience
    Argenta, LC
    Morykwas, MJ
    [J]. ANNALS OF PLASTIC SURGERY, 1997, 38 (06) : 563 - 576